Search Results - "Tosello, Celia"

Gene Expression Profile Associated with Response to Doxorubicin-Based Therapy in Breast Cancer by AZEVEDO KOIKE FOLGUEIRA, Maria Aparecida, CARRARO, Dirce Maria, REIS, Luiz Fernando, KAIANO, Jane Haruko, CAMARGO, Luiz Paulo, NICOLIELLO VENCIO, Ricardo Zorzetto, LONGO SNITCOVSKY, Igor Moysés, MAKDISSI, Fabiana Baroni, DA SILVA E SILVA, Paulo José, GUEDES SAMPAIO GOES, Joao Carlos, MITZI BRENTANI, Maria, BRENTANI, Helena, DA COSTA PATRAO, Diogo Ferreira, MANTOVANI BARBOSA, Edson, MOURAO NETTO, Mario, FIGARO CALDEIRA, José Roberto, HIRATA KATAYAMA, Maria Lucia, SOARES, Fernando Augusto, OLIVEIRA, Célia Tosello

“…Purpose: This study was designed to identify genes that could predict response to doxorubicin-based primary chemotherapy in breast cancer patients…”
Get full text

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid by CLEELAND, Charles S, BODY, Jean-Jacques, LIPTON, Allan, DE BOER, Richard, SALVAGNI, Stefania, TOSELLO OLIVEIRA, Celia, YI QIAN, QI JIANG, DANSEY, Roger, BRAUN, Ada, CHUNG, Karen, STOPECK, Alison, VON MOOS, Roger, FALLOWFIELD, Lesley, MATHIAS, Susan D, PATRICK, Donald L, CLEMONS, Mark, TONKIN, Katia, MASUDA, Norikazu

“…In this study, the authors evaluated the effect of denosumab versus zoledronic acid (ZA) on pain in patients with advanced breast cancer and bone metastases…”
Get full text

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative arimidex compared to tamoxifen (PROACT) trial by CATALIOTTI, Luigi, BUZDAR, Aman U, NOGUCHI, Shinzaburo, BINES, Jose, TAKATSUKA, Yuichi, PETRAKOVA, Katarina, DUBE, Pierre, DE OLIVEIRA, Celia Tosello

“…The Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative…”
Get full text

Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvant chemotherapy by AZEVEDO KOIKE FOLGUEIRA, Maria Aparecida, BRENTANI, Helena, MOURAO, Mario, FIGARO CALDEIRA, José Roberto, MITZI BRENTANI, Maria, CARRARO, Dirce Maria, DE CAMARGO BARROS, Mateus, HIRATA KATAYAMA, Maria Lucia, SANTANA DE ABREU, Ana Paula, MANTOVANI BARBOSA, Edson, TOSELLO DE OLIVEIRA, Celia, PATRAO, Diogo F. C, MOTA, Louise D

“…In breast cancer patients, primary chemotherapy is associated with the same survival benefits as adjuvant chemotherapy. Residual tumors represent a clinical…”
Get full text

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study) by Gómez, Henry L, Neciosup, Silvia, Tosello, Célia, Mano, Max, Bines, José, Ismael, Gustavo, Santi, Patrícia X, Pinczowski, Hélio, Nerón, Yeni, Fanelli, Marcello, Fein, Luis, Sampaio, Carlos, Lerzo, Guillermo, Capó, Adolfo, Zarba, Juan J, Blajman, César, Varela, Mirta S, Martínez-Mesa, Jeovany, Werutsky, Gustavo, Barrios, Carlos H

“…Micro-Abstract In LACOG 0801 phase II study 142 patients with HER2+ MBC with progression after taxane were randomized between Lapatinib (L) combined with…”
Get full text

A randomized double-blind phase II study of the combination of oral WX-671 plus capecitabine versus capecitabine monotherapy in first-line HER2-negative metastatic breast cancer (MBC) by Goldstein, Lori J., Oliveira, Celia Tosello, Heinrich, Bernhard, Stemmer, Salomon M., Mala, Carola, Kastner, Sabine, Bevan, Paul, Richters, Lisa, Schmalfeldt, Barbara, Harbeck, Nadia

“…Abstract only 508 Background: uPA and its inhibitor PAI-1 play a key role in tumor invasion, metastasis and tumor growth. uPA and PAI-1 are biomarkers…”
Get full text

Chemotherapy for advanced non-small cell lung cancer in the elderly population by Santos, Fábio Nasser, Castria, Tiago Biachi de, Cruz, Marcelo Rocha Souza, Riera, Rachel

“…Approximately 50% of patients with newly diagnosed non-small cell lung cancer (NSCLC) are over 70 years of age at diagnosis. Despite this fact, these patients…”
Get full text

A randomized, open-label, phase II study of lapatinib / capecitabine, lapatinib / vinorelbine, or lapatinib / gemcitabine in patients with ErbB2-amplified metastatic breast cancer progressing after taxane treatment: Results of an interim analysis (GLICO-0801 / EGF111792) by Gomez, Henry Leonidas, Neciosup, Silvia P., Tosello, Celia, Xavier, Patricia, Neron do Nascimento, Yeni, Fanelli, Marcelo, Ismael, Gustavo, Bines, Jose, Sampaio, Carlos, Lerzo, Guillermo Luis, Capo, Adolfo Miguel, Mano, Max S., Fein, Luis, Werutsky, Gustavo, Barrios, Carlos H.

“…Abstract only e11087 Background: Lapatinib-capecitabine is approved for the treatment of ErbB2-amplified metastatic breast cancer (MBC) after failure to…”
Get full text

Pain outcomes in patients with advanced breast cancer and bone metastases by Cleeland, Charles S., Body, Jean‐Jacques, Stopeck, Alison, von Moos, Roger, Fallowfield, Lesley, Mathias, Susan D., Patrick, Donald L., Clemons, Mark, Tonkin, Katia, Masuda, Norikazu, Lipton, Allan, de Boer, Richard, Salvagni, Stefania, Oliveira, Celia Tosello, Qian, Yi, Jiang, Qi, Dansey, Roger, Braun, Ada, Chung, Karen

“…BACKGROUND: In this study, the authors evaluated the effect of denosumab versus zoledronic acid (ZA) on pain in patients with advanced breast cancer and bone…”
Get full text

Phase I/II Pharmacokinetic Study of Pemetrexed and Epirubicin in Patients with Locally Advanced or Metastatic Breast Cancer by Paridaens, Robert, Dirix, Luc, Dumez, Herlinde, Prové, Annemie, Wildiers, Hans, Alvarez, Ana, Oliveira, Celia Tosello, Latz, Jane, Simms, Lorinda, Melemed, Allen

“…Abstract Background Pemetrexed and epirubicin are each active in patients with advanced/metastatic breast cancer (MBC). This phase I/II study evaluated these…”
Get full text

Biomonitoring of nurses handling antineoplastic drugs by Machado-Santelli, G M, Cerqueira, E M, Oliveira, C T, Pereira, C A

“…The micronuclei analysis in exfoliated cells of the buccal cavity was employed in the cytogenetic monitoring of nurses handling antineoplastic drugs. The group…”
Get more information

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor‐positive breast cancer by Cataliotti, Luigi, Buzdar, Aman U., Noguchi, Shinzaburo, Bines, Jose, Takatsuka, Yuichi, Petrakova, Katarina, Dube, Pierre, Tosello de Oliveira, Celia

“…BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a…”
Get full text

Tumor residual pós-quimioterapia neoadjuvante para câncer de mama: impacto sobre o tratamento cirúrgico conservador Residual tumor after neoadjuvant chemotherapy for breast cancer: impact on conservative surgical treatment by Edison Mantovani Barbosa, Nídia Fabrega Donoso, Cynthia Aparecida Bueno T. Osório, Eloá Muniz F. Alves, Fátima Cristina Waldvogel, Célia Tosello Oliveira, João Carlos Sampaio Góes

“…Objetivo: analisar as alterações histopatológicas provocadas pela ação da quimioterapia neoadjuvante (fluoracil, epirrubicina e ciclofosfamida; FEC -- 4…”
Get full text

Tumor residual pós-quimioterapia neoadjuvante para câncer de mama: impacto sobre o tratamento cirúrgico conservador by Barbosa, Edison Mantovani, Donoso, Nídia Fabrega, Osório, Cynthia Aparecida Bueno T., Alves, Eloá Muniz F., Waldvogel, Fátima Cristina, Oliveira, Célia Tosello, Góes, João Carlos Sampaio

“…Objetivo: analisar as alterações histopatológicas provocadas pela ação da quimioterapia neoadjuvante (fluoracil, epirrubicina e ciclofosfamida; FEC -- 4…”
Get full text